tirzepatide fda news Eli Lilly sues companies selling alternative versions of its weight loss drug FDA approval for Zepbound: FSU

Kurz, J

Summary: GLP-1 receptor agonists are prescription medications that may support weight management during perimenopause by suppressing appetite and delaying gastric emptying, but they are not specifically indicated for hormonal changes and require strict NHS eligibility criteria

Site Rotation Rotate sites every injection to prevent local irritation and lipohypertrophy

Can Tirzepatide Affect Your Period

This dual action enhances its ability to manage blood sugar levels and offers additional metabolic benefits

The defendants include Novo Nordisk, which manufactures Ozempic, Wegovy, and Rybelsus (all containing semaglutide), and Eli Lilly, which manufactures Mounjaro (containing tirzepatide)